Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program

By sjmartinez • August 8, 2023

Arbanas JC, Damberg CL, Leng M, Harawa N, Sarkisian CA, Landon BE, Mafi JN. Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program. JAMA Intern Med. 2023 Aug 1;183(8):885-889. doi: 10.1001/jamainternmed.2023.1749. PMID: 37167598; PMCID: PMC10176174.

Tags: General Internal Medicine, Publications

Systematic Review: Association Between Physicians’ Clinical Experience and Quality of Care and Patient Outcomes

Shimada M, Kuno T, Shindo Y, Iwagami M, Tsugawa Y. Systematic Review: Association Between Physicians' Clinical Experience and Quality of Care and Patient Outcomes. J[...]

Financial Protection in Flux: Longitudinal Evidence on Out-of-Pocket Spending Among Middle-Aged and Older Mexicans During the Seguro Popular-INSABI Transition

Cabrero-Castro JE, Gonzalez M, Aguila E, Arreola-Ornelas H, Touchton M, Knaul FM, Rojas-Alvarez A. Financial Protection in Flux: Longitudinal Evidence on Out-of-Pocket Spending Among Middle-Aged[...]

Estimating an intervention’s effects on health care disparities within and between physician organizations: decomposing the effects of health system affiliation

DeYoreo M, Agniel D, Zhang S, Escarce JJ, Timbie JW. Estimating an intervention's effects on health care disparities within and between physician organizations: decomposing the[...]